Home › Research › Drug development
The social construction of Aduhelm in the context of pharmaceutical ambiguity: exploring narratives from informal caregivers, medical professionals, and redditors on r/Alzheimers
Zack Simoni, Victoria Hilfiker. Frontiers in Sociology, 2026-01-05
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Our findings reveal various concerns about Aduhelm involving efficacy, safety, and affordability. Most notably, we find these narratives increased a sense of medical mistrust from participants, which may be problematic for adherence and the doctor/patient interaction. Drawing on sociological literature, we introduce the concept of pharmaceutical ambiguity, a theoretical framework for understanding these social phenomena. This study highlights how controversies like that surrounding Aduhelm can deeply erode trust in medical systems.
What this study adds
Evidence grade: Low
This study examined how caregivers, medical professionals and Reddit users talked about the Alzheimer's drug Aduhelm, finding concerns about efficacy, safety and affordability that increased medical mistrust. It is about social reactions to a drug, not about whether any treatment cures or prevents Alzheimer's disease.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Simoni, Z., & Hilfiker, V. (2026). The social construction of Aduhelm in the context of pharmaceutical ambiguity: exploring narratives from informal caregivers, medical professionals, and redditors on r/Alzheimers. Frontiers in Sociology. https://doi.org/10.3389/fsoc.2025.1636160
Vancouver
Simoni Z, Hilfiker V. The social construction of Aduhelm in the context of pharmaceutical ambiguity: exploring narratives from informal caregivers, medical professionals, and redditors on r/Alzheimers. Frontiers in Sociology. 2026. doi:10.3389/fsoc.2025.1636160. PMID: 41561789.
BibTeX
@article{simoni2026-41561789,
author = {Simoni, Zack and Hilfiker, Victoria},
title = {{The social construction of Aduhelm in the context of pharmaceutical ambiguity: exploring narratives from informal caregivers, medical professionals, and redditors on r/Alzheimers}},
journal = {Frontiers in Sociology},
year = {2026},
doi = {10.3389/fsoc.2025.1636160},
pmid = {41561789},
url = {https://doi.org/10.3389/fsoc.2025.1636160}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Our findings reveal various concerns about Aduhelm involving efficacy, safety, and affordability.
- Most notably, we find these narratives increased a sense of medical mistrust from participants, which may be problematic for adherence and the doctor/patient interaction.
- Drawing on sociological literature, we introduce the concept of pharmaceutical ambiguity, a theoretical framework for understanding these social phenomena.
- This study highlights how controversies like that surrounding Aduhelm can deeply erode trust in medical systems.
Why it matters
This study examined how caregivers, medical professionals and Reddit users talked about the Alzheimer's drug Aduhelm, finding concerns about efficacy, safety and affordability that increased medical mistrust. It is about social reactions to a drug, not about whether any treatment cures or prevents Alzheimer's disease.
New to this subject? Start with our plain-English guide: Treatments →
Study details
- Evidence strengthLow
How this study scored 28/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 27 of the 96 points we could judge it on, which is 28 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Frontiers in Sociology) |
| Journal's citation record | 0 / 4 | Frontiers in Sociology: journal h-index 52 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 0 / 7 | Cited 0 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.0 citations a year over 2 year(s) since 2026 |
| Impact for its field and year | 0 / 6 | Cited 0.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | — / 4 | OpenAlex's profile for last-listed author Victoria Hilfiker holds only 2 work(s), too few to judge a track record — left out of this score |
| Institution's track record | 0 / 3 | University of Tennessee at Chattanooga: institution h-index 184 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41561789) |
| Free to read | 2 / 2 | Free to read |
| Points | 27 / 96 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 27 of the 96 points we could judge it on is 28 out of 100. |
| Total | 28 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.3389/fsoc.2025.1636160
- PubMed: 41561789
- Original source →
- Free full text: Frontiers in Sociology →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Drug development from nearby years
Also in Drug development
107 studies in the library are filed under Drug development with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Drug development hub.